Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria. [PDF]
Giménez-Arnau AM +11 more
europepmc +1 more source
Is it possible to use complete blood collection based systemic inflammatory indices as potential biomarkers for chronic spontaneous urticaria. [PDF]
Li B +8 more
europepmc +1 more source
An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment. [PDF]
Tbakhi B +4 more
europepmc +1 more source
[Advances in targeted therapies for chronic spontaneous urticaria]. [PDF]
Zhou L, Hu C, Wang S, Zhang R.
europepmc +1 more source
Nanomaterials in Targeted Immunotherapy for Chronic Spontaneous Urticaria: Focusing on Immune Cell Modulation and Precision Treatment. [PDF]
Yao W +7 more
europepmc +1 more source
Co-existence of chronic spontaneous urticaria with atopic dermatitis: clinical and immunological perspectives. [PDF]
Toubi E, Mubariki R, Vadasz Z.
europepmc +1 more source
Successful treatment of chronic spontaneous urticaria and bladder pain syndrome with montelukast and/or omalizumab: a case report. [PDF]
Bulut G.
europepmc +1 more source

